IL27 Antikörper (N-Term)
Kurzübersicht für IL27 Antikörper (N-Term) (ABIN500000)
Target
Alle IL27 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody reacts to IL-27.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- Affinity chromatography purified via peptide column
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA. Western Blot: 2 - 4 μg/mL. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
-
- IL27 (Interleukin-27 Subunit alpha (IL27))
-
Andere Bezeichnung
- Interleukin-27 / IL27A
-
Hintergrund
- Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naive but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-γ, and T-bet.Synonyms: IL-27 subunit alpha, IL-30, IL27-A, IL30, Interleukin-30, p28
-
Gen-ID
- 246778
-
NCBI Accession
- NP_663634
-
UniProt
- Q8NEV9
Target
-